e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Tuberculosis and HIV coinfection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Site of active tuberculosis disease predicts survival in HIV-associated tuberculosis
O. Arghir, C. Ciobotaru, M. Man, M. Trenchea, S. Rugina (Constantza, Cluj Napoca, Constanta, Romania)
Source:
Annual Congress 2010 - Tuberculosis and HIV coinfection
Session:
Tuberculosis and HIV coinfection
Session type:
Oral Presentation
Number:
3865
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Arghir, C. Ciobotaru, M. Man, M. Trenchea, S. Rugina (Constantza, Cluj Napoca, Constanta, Romania). Site of active tuberculosis disease predicts survival in HIV-associated tuberculosis. Eur Respir J 2010; 36: Suppl. 54, 3865
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018
Latent tuberculosis infection as a cause of tuberculosis disease
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003
Knowledge of tuberculosis patients about tuberculosis disease
Source: Eur Respir J 2006; 28: Suppl. 50, 19s
Year: 2006
Crohn‘s disease or extrapulmonary tuberculosis?
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
Profiles of tuberculosis disease activation among contacts of patients with tuberculosis
Source: Eur Respir J, 54 (4) 1900353; 10.1183/13993003.00353-2019
Year: 2019
The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Multiple cytokine response to
mycobacterium tuberculosis
with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
The definition of tuberculosis infection based on the spectrum of tuberculosis disease
Source: Breathe, 17 (3) 210079; 10.1183/20734735.0079-2021
Year: 2021
Risk of disease and latent infection among contacts of pulmonary and pleural tuberculosis in santarem (Portugal)
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
Source: Eur Respir J 2016; 48: 1751-1763
Year: 2016
Who is at risk for active tuberculosis?
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003
Timing of relapse of tuberculosis in people with co-infection (HIV/TB)
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine.
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018
Performance and post-treatment conversion of latent tuberculosis test (QUANTIFERON) in immunocompromised patients with neoplasmatic disease
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Progression to tuberculosis disease increases with multiple exposures
Source: Eur Respir J 2016; 48: 1682-1689
Year: 2016
Treatment failure in tuberculosis
Source: Eur Respir J 2007; 29: 561-564
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept